US 9370510
Small molecule compounds to treat hearing loss
granted A61KA61K31/404A61K31/475
Quick answer
US patent 9370510 (Small molecule compounds to treat hearing loss) held by Fate Therapeutics, Inc. expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/404, A61K31/475, A61K31/506, A61K31/55